You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

MASS. MOVERS

Judge allows sales of Momenta drug copy

Bloomberg News/File

Momenta gets revenue from generic Lovenox sold by partner Novartis AG’s Sandoz unit.

Shares of Momenta Pharmaceuticals Inc., a Cambridge company that owns patents on the blood-thinner Lovenox, fell after a court cleared the way for Watson Pharmaceuticals to sell a generic version of the drug. The US Court of Appeals for the Federal Circuit granted Watson partner Amphastar Pharmaceuticals a stay of an order that prevented sales. A US judge in Boston blocked sales of the drug copy, saying Momenta was likely to win a patent-infringement suit it had filed. The Federal Circuit said its order “does not represent a final decision’’ on the merits of the appeal.

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week